We found that hypomethylation of BIN1 promoter was associated with early pathological changes in preclinical AD, which is consistent with previous studies on brain tissue showing that methylation at some CpG sites in BIN1 was associated with Aβ load and tau tangle density15,16. The gene discussed is BIN1; the disease is Alzheimer disease.